AnaptysBio Correlations
| ANAB Stock | USD 55.05 1.06 1.89% |
The current 90-days correlation between AnaptysBio and Xencor Inc is 0.46 (i.e., Very weak diversification). The correlation of AnaptysBio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
AnaptysBio Correlation With Market
Poor diversification
The correlation between AnaptysBio and DJI is 0.67 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and DJI in the same portfolio, assuming nothing else is changed.
AnaptysBio | Build AI portfolio with AnaptysBio Stock |
Moving together with AnaptysBio Stock
| 0.63 | GXEA | Galapagos NV | PairCorr |
| 0.84 | EQ | Equillium | PairCorr |
| 0.61 | VALN | Valneva SE ADR | PairCorr |
| 0.63 | 6C1 | CytomX Therapeutics Earnings Call This Week | PairCorr |
| 0.73 | DRTS | Alpha Tau Medical Earnings Call This Week | PairCorr |
| 0.73 | DSGN | Design Therapeutics | PairCorr |
| 0.67 | 0P6S | Bayer AG NA Earnings Call This Week | PairCorr |
| 0.61 | VINC | Vincerx Pharma Common | PairCorr |
| 0.65 | DVAX | Dynavax Technologies | PairCorr |
Moving against AnaptysBio Stock
| 0.82 | VCYT | Veracyte | PairCorr |
| 0.78 | OSE | OSE Pharma SA | PairCorr |
| 0.68 | RAC | Race Oncology | PairCorr |
| 0.43 | VCEL | Vericel Corp Ord Downward Rally | PairCorr |
| 0.4 | OB3 | OPTIBIOTIX HLTH PLC | PairCorr |
| 0.38 | VANI | Vivani Medical | PairCorr |
| 0.85 | DRMA | Dermata Therapeutics | PairCorr |
| 0.67 | DTIL | Precision BioSciences | PairCorr |
| 0.63 | ABNX | Abionyx Pharma SA Earnings Call This Week | PairCorr |
| 0.34 | DXB | Dimerix | PairCorr |
| 0.77 | 9OF | BIORESTORATTHERAPDL | PairCorr |
| 0.68 | DYAI | Dyadic International | PairCorr |
| 0.67 | BIM | Biomerieux SA | PairCorr |
| 0.66 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.65 | IGS1 | India Globalization | PairCorr |
| 0.42 | VKTX | Viking Therapeutics | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between AnaptysBio Stock performing well and AnaptysBio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AnaptysBio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XNCR | 2.78 | (0.42) | 0.00 | (0.43) | 0.00 | 6.33 | 16.84 | |||
| OCS | 2.03 | 0.62 | 0.26 | 1.12 | 1.66 | 5.79 | 16.37 | |||
| PHAT | 3.14 | (0.22) | 0.00 | (0.49) | 0.00 | 7.68 | 24.16 | |||
| MNMD | 3.07 | 0.41 | 0.09 | 3.67 | 3.40 | 6.21 | 28.06 | |||
| URGN | 2.91 | (0.24) | 0.00 | (0.41) | 0.00 | 5.40 | 20.58 | |||
| NRIX | 2.66 | (0.09) | (0.03) | (0.01) | 3.20 | 5.64 | 27.63 | |||
| BBOT | 3.45 | (0.28) | 0.00 | (0.24) | 0.00 | 9.92 | 31.80 | |||
| KOD | 4.22 | 0.42 | 0.10 | 0.44 | 3.93 | 9.66 | 23.68 | |||
| DNTH | 2.78 | 0.54 | 0.14 | (0.95) | 2.59 | 6.30 | 22.93 | |||
| TSHA | 3.35 | 0.11 | 0.03 | 0.17 | 3.93 | 7.57 | 21.14 |
AnaptysBio Corporate Management
| Martin Dahl | Senior Research | Profile | |
| Monique Silva | Senior Affairs | Profile | |
| James MD | Advisor | Profile | |
| David McKeon | Senior Controller | Profile | |
| Beth Mueller | Senior Resources | Profile | |
| Priya Raina | Senior Operations | Profile | |
| FAAD MBA | Chief Officer | Profile |